MAPK3 and leukemia: This analysis identified several key gene targets that dehydrovomifoliol might influence in the context of leukemia, including TNF, AKT1, IL6, ALB, HSP90AA1, EGFR, ESR1, MAPK3, CASP3, and SRC (Fig. S5).